Literature DB >> 32203673

Right Ventricle-to-Left Ventricle Diameter Ratio Measurement Seems to Have No Role in Low-Risk Patients with Pulmonary Embolism Treated at Home Triaged by Hestia Criteria.

Stephan V Hendriks1,2, Frederikus A Klok1, Paul L den Exter1, Michiel Eijsvogel3, Laura M Faber4, Herman M A Hofstee5, Antonio Iglesias Del Sol6, Lucia J M Kroft1, Albert T A Mairuhu2, Menno V Huisman1.   

Abstract

Entities:  

Year:  2020        PMID： 32203673     DOI： 10.1164/rccm.202002-0267LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

Review 1.  Prognostic Performance of Hestia Criteria in Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis.

Authors:  Yubin Wang; Yinhe Feng; Rao Du; Xiaoya Yang; Jifeng Huang; Hui Mao
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

2.  Listen to Your Heart (but DON'T Look at Theirs): Risk Assessment for Home Treatment of Pulmonary Embolism.

Authors:  Gregory Piazza
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

3.  Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial.

Authors:  Pierre-Marie Roy; Andrea Penaloza; Olivier Hugli; Frederikus A Klok; Armelle Arnoux; Antoine Elias; Francis Couturaud; Luc-Marie Joly; Raphaëlle Lopez; Laura M Faber; Marie Daoud-Elias; Benjamin Planquette; Jérôme Bokobza; Damien Viglino; Jeannot Schmidt; Henry Juchet; Isabelle Mahe; Frits Mulder; Magali Bartiaux; Rosen Cren; Thomas Moumneh; Isabelle Quere; Nicolas Falvo; Karine Montaclair; Delphine Douillet; Charlotte Steinier; Stephan V Hendriks; Ygal Benhamou; Tali-Anne Szwebel; Gilles Pernod; Nicolas Dublanchet; François-Xavier Lapebie; Nicolas Javaud; Alexandre Ghuysen; Mustapha Sebbane; Gilles Chatellier; Guy Meyer; David Jimenez; Menno V Huisman; Olivier Sanchez
Journal:  Eur Heart J       Date:  2021-08-31       Impact factor: 29.983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.